# Blackrock Neuromed

- Location (FDA's records): Salt Lake City, UT
- FDA decisions: 2 (2013–2016): 2 510(k) clearances
- Names in FDA's records: Blackrock Neuromed (1); Blackrock Neuromed, LLC (1)
- Product codes: GYC (1), GWQ (1)
- Predicates its devices cite: 7 (0 its own); citations of its devices by later devices: 3 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Cardinal Health, Inc.: 1 (https://510kreport.com/company/cardinal-health)
- Radionics, Inc.: 1 (https://510kreport.com/company/radionics)
- Nihon Kohden Corporation: 1 (https://510kreport.com/company/nihon-kohden)
- Chatten Associates, Inc.: 1 (https://510kreport.com/company/chatten-associates)
- I2s Micro Implantable Systems, LLC: 1 (https://510kreport.com/company/i2s-micro-implantable-systems)
- Micromed S.P.A.: 1 (https://510kreport.com/company/micromed)
- Airsep Corp.: 1 (https://510kreport.com/company/airsep)

## Firms that cite its devices most
- Micromed S.P.A.: 2 (https://510kreport.com/company/micromed)
- Neurosoft, Inc.: 1 (https://510kreport.com/company/neurosoft)

## Its most-cited devices
- K122196: Cervello Bio-Potential Signal Acquistion System Product Family (2013), cited by 2
- K151354: Cervello STIM (2016), cited by 1

## Recent decisions
- K151354: Cervello STIM (Jan 27, 2016)
- K122196: Cervello Bio-Potential Signal Acquistion System Product Family (May 2, 2013)

Source page: https://510kreport.com/company/blackrock-neuromed